Raymond Ruff

Science TLDR

Ten-minute paper summaries for scientists and experts. Two episodes a week: Mondays feature the top-scoring paper from a curated weekly digest of T cell engager, bispecific antibody, and protein engineering literature. Fridays cover the top trending paper on PubMed — any field, whatever's catching the research community's attention that week. Hosted by Raymond Ruff, a protein scientist working in translational immunotherapeutics. Audio is generated with NotebookLM; the host prompt aims for measured scientific skepticism rather than hype. Feedback and paper suggestions: sciencetldrpod@gmail.com

No dejes de visitar la web del podcast y apoyar a su creador: raymondruff.github.io

Autor

Raymond Ruff

Categoría

Science

Web del podcast

raymondruff.github.io

Último episodio

20 de nov. de 2026

¿Dónde escuchar?

Podcasts en la app Replaio Radio Muy pronto

Los podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts

Descárgala en Google Play Instálala gratis Android 10 M+ de descargas · valoración de 4,7+ iOS muy pronto

Episodios

Episode 102: Trending — Recombinant Canine Coronaviruses in Dogs, Europe 20.11.2026

Top Trending Friday — our weekly pick of the most-discussed paper on PubMed this week. Recombinant Canine Coronaviruses in Dogs, Europe Emerging Infectious Diseases, 2010 DOI: 10.3201/eid1601.090726 Question: How common in European dogs are canine coronavirus (CCoV) type II strains whose spike 5' end is recombinant with porcine TGEV? Answer: In 1,172 faecal samples from dogs with enteritis in 14 c...

Episode 101: Seasonal variations of functional connectivity of human brains 18.11.2026

Seasonal variations of functional connectivity of human brains Scientific Reports, 2023 DOI: 10.1038/s41598-023-43152-4 Question: Does resting-state fMRI activity and connectivity differ with the season in which a person is scanned? Answer: In 410 Human Connectome Project adults, each measured at one time of year, low-frequency signal power (fALFF) and some connectivity measures peaked in autumn....

Episode 100: T cell–mediated antibody-dependent cellular cytotoxicity provides a therapeutic approach for solid cancers 16.11.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. T cell–mediated antibody-dependent cellular cytotoxicity provides a therapeutic approach for solid cancers JCI Insight, 2026 DOI: 10.1172/jci.insight.205984 Question: Can the native FcγRI signalling module's antigen-density threshold make redirected T cell killing tumour-selective? Answer: AG2G T cells signalled only ab...

Episode 99: Reddit Trending — Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation 13.11.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation PLOS Medicine, 2026 DOI: 10.1371/journal.pmed.1004772 Question: Did the $79.4 billion spent developing and delivering COVID-19 vaccines in 2020–21 pay off globally in the first year...

Episode 98: Biomolecular design through latent reasoning with RFD4-Proteina 11.11.2026

Biomolecular design through latent reasoning with RFD4-Proteina White paper — UW Institute for Protein Design & NVIDIA, 2026 Source: https://rfd4-proteina.org/assets/paper/RFD4-Proteina.pdf Question: Can one generative model span proteins, sugars, DNA and RNA in a shared latent space, and does inference-time compute improve real design success? Answer: On the authors' own AF3-judged benchmarks...

Episode 97: Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments. 10.11.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments Molecular Cancer Therapeutics, 2026 DOI: 10.1158/1535-7163.MCT-25-1542 Question: Does HERV-K (HML-2) envelope mark clinically relevant DLBCL states, and is it a usable surface target? Answer: HERV expression mirrors the ABC...

Episode 96: Reddit Trending — The dietary fibre content of fruit and vegetable kitchen preparation waste and UK consumers’ dietary fibre-related attitudes regarding its consumption 07.11.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. The dietary fibre content of fruit and vegetable kitchen preparation waste and UK consumers' dietary fibre-related attitudes regarding its consumption International Journal of Food Sciences and Nutrition, 2026 DOI: 10.1080/09637486.2026.2734852 Question: Do discarded peels, stalks, cores and seeds of 12 fruits...

Episode 95: Shared α-helix chimeraffibodies enable linker-free bispecific protein design 04.11.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Shared α-helix chimeraffibodies enable linker-free bispecific protein design Cell Chemical Biology, 2026 DOI: 10.1016/j.chembiol.2026.09.022 Question: Can two α-helical binding domains be fused by sharing a single helix instead of a flexible linker, without destroying either paratope? Answer: Yes for one lineage: the le...

Episode 94: Reddit Trending — The Effect of Deactivating Facebook and Instagram on Users’ Emotional State 01.11.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. The Effect of Deactivating Facebook and Instagram on Users’ Emotional State American Economic Journal: Economic Policy, 2024 DOI: 10.1257/pol.20240806 Question: Does deactivating Facebook or Instagram for six weeks improve users' self-reported happiness, depression and anxiety? Answer: Facebook deactivation imp...

Episode 93: Reddit Trending — Associations of food processing and dietary risk factors with colorectal cancer incidence in the NIH-AARP Diet and Health Study: A cohort study 23.10.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Associations of food processing and dietary risk factors with colorectal cancer incidence in the NIH-AARP Diet and Health Study: A cohort study PLOS Medicine, 2026 DOI: 10.1371/journal.pmed.1005251 Question: Is total ultra-processed food (UPF) intake associated with colorectal cancer, and which nutrients inside...

Episode 92: Engineered TYK2 dependence enables myeloid-selective IL-10 receptor agonism 19.10.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Engineered TYK2 dependence enables myeloid-selective IL-10 receptor agonism Nature, 2026 DOI: 10.1038/s41586-026-11176-1 Question: Can IL-10 receptor agonism be made to suppress myeloid cells without also activating T cells, which drives IL-10's clinical toxicity? Answer: A tetravalent nanobody agonist (lead E07/A05) su...

Episode 91: Reddit Trending — “It’s Like You’re Trying to Defuse a Bomb”: <i>Fear, Responsibility, and Shame in Young Men’s Sexual Lives</i> 18.10.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. "It's Like You're Trying to Defuse a Bomb": Fear, Responsibility, and Shame in Young Men's Sexual Lives Journal of Sex &amp; Marital Therapy, 2026 DOI: 10.1080/0092623X.2026.2740624 Question: How do young heterosexual men, raised amid consent-focused sex education, emotionally experience sex? Answer: In 31 inte...

Episode 90: Validation and analysis of 12,000 AI-driven CAR-T designs in the Bits to Binders competition 13.10.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Validation and analysis of 12,000 AI-driven CAR-T designs in the Bits to Binders competition Molecular Systems Biology, 2026 DOI: 10.1038/s44320-026-00246-1 Question: Do AI-designed minibinders function as CAR-T antigen-recognition domains, not just as high-affinity binders in isolation? Answer: Across 12,000 designs fr...

Episode 89: Reddit Trending — Not with a Bang but a Whimper: Congressional Silence Amid an Historic Assault on the Power of the Purse 09.10.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Not with a Bang but a Whimper: Congressional Silence Amid an Historic Assault on the Power of the Purse PS: Political Science &amp; Politics, 2025 DOI: 10.1017/S1049096525101704 Question: Why has Congress barely resisted President Trump's unilateral impoundments and tariffs, actions that assault its constitutio...

Episode 88: GPCR antagonism via rewiring of receptor trafficking and degradation 07.10.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. GPCR antagonism via rewiring of receptor trafficking and degradation Nature, 2026 DOI: 10.1038/s41586-026-11088-0 Question: Can bispecific antibodies that hijack transferrin receptor 1 trafficking degrade GPCRs that are hard to block with conventional antagonists? Answer: Yes in overexpression systems and one short-term...

Episode 87: Reddit Trending — Did Donald Trump Receive a Mandate for Sweeping Change in 2024? 06.10.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Did Donald Trump Receive a Mandate for Sweeping Change in 2024? PS: Political Science &amp; Politics, 2025 DOI: 10.1017/S1049096525101868 Question: Did Trump's 2024 victory and subsequent polling give him a genuine public mandate for the sweeping changes he and his team claimed? Answer: No, by the author's crit...

Episode 86: Specific targeting of MR1-antigen complexes using nanobodies 05.10.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Specific targeting of MR1-antigen complexes using nanobodies Science Immunology, 2025 DOI: 10.1126/sciimmunol.aeb8726 Question: Can nanobodies be raised to selectively recognize MR1 only when it presents a spec

Episode 85: Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits 04.10.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits Cell, 2026 DOI: 10.1016/j.cell.2026.08.002 Question: Can genome-scale CRISPRi perturb-seq in primary human CD4+ T cells, at rest and after stimulation, map which genes regulate T cell states...

Episode 84: Reddit Trending — Predictors and prevalence of support for white nationalism in the United States 03.10.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Predictors and prevalence of support for white nationalism in the United States Nature, 2026 DOI: 10.1038/s41586-026-11018-0 Question: How common is explicit, informed support for white nationalism among white US adults, and what predicts it? Answer: In a probability sample, 4.9% (CI 3.6–6.2) of non-Hispanic wh...

Episode 83: Discovery and engineering of bispecific TCR-mimic antibodies targeting peptide–HLA complex 26.09.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Discovery and engineering of bispecific TCR-mimic antibodies targeting peptide–HLA complex mAbs, 2026 DOI: 10.1080/19420862.2026.2731282 Question: Can building proteome-wide off-target counter-screening into TCR-mimic antibody discovery yield more specific WT1-targeting bispecifics than published comparators? Answer: Th...

Episode 82: Trending — Substantial under-detection of human rabies cases in the United States 25.09.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Substantial under-detection of human rabies cases in the United States Communications Health, 2026 DOI: 10.1038/s44528-026-00031-4 Question: Using rare transplant-transmitted rabies events as a proxy sample of undiagnosed deaths, how many US rabies deaths does official surveillance actually miss? Answer: Scalin...

Episode 81: A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability 25.08.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Paper: A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability Authors: M. Frank Erasmus, Daniel Bedinger, Elizabeth Hopkins, Ginger Ferguson, et al. Journal: Nature Biotechnology, 2026 Why it matters: This CASP-style blinded benchmark—testing 511 AI-designed...

Episode 80: Trending — Educational expansion and the hidden reversal of the Flynn effect—Differential trends across socioeconomic strata 22.07.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Paper: Educational expansion and the hidden reversal of the Flynn effect—Differential trends across socioeconomic strata Authors: Bernt Bratsberg, Anders M. Fjell, Ole J. Rogeberg, Kristine B. Walhovd Journal: Proceedings of the National Academy of Sciences, 2025 Why it matters: The apparent plateau and reversa...

Episode 79: Trending — Probability of a timely vocal response in mother-infant interaction and later psychiatric diagnosis: A case-control study 16.07.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Paper: Probability of a timely vocal response in mother-infant interaction and later psychiatric diagnosis: A case-control study Authors: Bethany Stanley, Clare S. Allely, Jenna Charlton, Christopher Gillberg, et al. Journal: PLOS One, 2024 Why it matters: A single timing metric — whether a mother vocalizes bac...

Episode 78: Covalently PD‐L1 Anchoring Drives Bispecific Nanostructure Assembly for Spatial Control of T Cell Recruitment and Activation 06.07.2026

**Monday Immune Engager** — our weekly pick from the latest immune-engager digest. **Paper:** [Covalently PD‐L1 Anchoring Drives Bispecific Nanostructure Assembly for Spatial Control of T Cell Recruitment and Activation](https://doi.org/10.1002/anie.5894316) **Authors:** Fengzhen Zhang, Yuhan Dong, Kailu Liu, Hui Hu, et al. **Journal:** Angewandte Chemie International Edition, 2025 **Why it matter...

Escucha el podcast Science TLDR en Replaio

Radio y podcasts en una sola app - gratis y sin registro. Instálala hoy y no te pierdas el estreno

Descárgala en Google Play

Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos